Mediterranean diet as a protective factor for wheezing in preschool children

Jose A Castro-Rodriguez1, Luis Garcia-Marcos, Juan D Alfonseda Rojas

  • 1School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. jacastro17@hotmail.com

Insights

The Mediterranean diet may protect preschoolers from wheezing. This dietary pattern is an independent protective factor, regardless of obesity or physical activity levels.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Epidemiology
  • Respiratory Health

Background:

  • Wheezing is a common respiratory symptom in preschoolers.
  • Identifying modifiable protective factors is crucial for early intervention.
  • The Mediterranean diet's potential role in respiratory health requires further investigation.

Purpose of the Study:

  • To evaluate the Mediterranean diet as a protective factor against current wheezing in preschoolers.
  • To determine if this association is independent of other known risk factors and obesity.

Main Methods:

  • A cross-sectional study involving 1784 preschoolers and parental questionnaires.
  • Wheezing status was assessed for the previous year.
  • A Mediterranean diet score was calculated based on food intake frequency.

Main Results:

  • The Mediterranean diet was associated with reduced current wheezing in preschoolers.
  • Factors like eczema, rhinoconjunctivitis, paternal asthma, and acetaminophen use were identified as risk factors.
  • The Mediterranean diet demonstrated a protective effect (adjusted odds ratio = 0.54).

Conclusions:

  • The Mediterranean diet is an independent protective factor for current wheezing in preschoolers.
  • This protective effect is observed irrespective of obesity and physical activity.
  • Promoting Mediterranean dietary patterns may be beneficial for preschooler respiratory health.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: